Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum

References

• Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS — 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515–548
   PubMed Web of Science ®Google Scholar
• Bolaños B, Mitchell TG. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. J Leukoc Biol 1989; 46: 521–528
   PubMed Web of Science ®Google Scholar
• Davies SF, Clifford DP, Hoidal JR, Repine JE. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. J Infect Dis 1982; 145: 870–874
   PubMed Web of Science ®Google Scholar
• Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun 1994; 62: 194–202
   PubMed Web of Science ®Google Scholar
• Huffnagle, GB, Lipscomb, MF, Lovehik, JA, et al. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994; 55: 35–42
   PubMed Web of Science ®Google Scholar
• Mody, CH, Chen, GH, Jackson, C, et al. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J Lab Clin Med 1993; 121: 765–773
   PubMed Web of Science ®Google Scholar
• Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995; 63: 1725–1731
   PubMed Web of Science ®Google Scholar
• Cross CE, Bancroft GJ. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and β-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun 1995; 63: 2604–2611
   PubMed Web of Science ®Google Scholar
• Levitz, SM, Tabuni, A, Kornfeld, H, et al. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun 1994; 62: 1975–1981
   PubMed Web of Science ®Google Scholar
• Chen, GH, Curtis, JL, Mody, CH, et al. Effect of granulocytemacrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J Immunol 1994; 152: 724–734
   PubMed Web of Science ®Google Scholar
• Levitz SM. Activation of human peripheral blood mononuclear cells by interleukin 2 and granulocyte-macrophage colonystimulating factor to inhibit Cryptococcus neoformans. Infect Immun 1991; 59: 3393–3397
   PubMed Web of Science ®Google Scholar
• Mukherjee J, Scharff MD, Casadevlla A. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect Immun 1995; 63: 3353–3359
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Feldmesser M, Casadevall A. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J Infect Dis 1996; 173: 1222–1231
   PubMed Web of Science ®Google Scholar
• Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62: 4755–4761
   PubMed Web of Science ®Google Scholar
• Muth SM, Murphy JW. Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect Immun 1995; 63: 1637–1644
   PubMed Web of Science ®Google Scholar
• Sanford JE, Lupan DM, Schlageter AM, Kozel TR. Passive immunization against Cryptococcus neoformans with an isotypeswitch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect Immun 1990; 58: 1919–1923
   PubMed Web of Science ®Google Scholar
• Bolaños B, Mitchell TG. Killing of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol 1989; 27: 219–228
   PubMedGoogle Scholar
• Bolaños B, Mitchell TG. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol 1989; 27: 203–217
   PubMedGoogle Scholar
• Small JM, Mitchell TG, Wheat RW. Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A. Infect Immun 1986; 54: 735–741
   PubMed Web of Science ®Google Scholar
• Kozel TR, Cazin J. Non-encapsulated variant of Cryptococcus neoformans. I. Virulence studies and characterization of soluble polysaccharide. Infect Immun 1971; 3: 287–294
   PubMed Web of Science ®Google Scholar
• Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother 1987; 31: 6–10
   PubMed Web of Science ®Google Scholar
• Maccani JE. Detection of cryptococcal polysaccharide using counterimmunoelectrophoresis. Am J Clin Pathol 1977; 68: 39–44
   PubMed Web of Science ®Google Scholar
• Van Snick J. Interleukin 6: an overview. Annu Rev Immunol 1990; 8: 253–278
   PubMed Web of Science ®Google Scholar
• Griffin FM. Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans. Proc Natl Acad Sci USA 1981; 78: 3853–3857
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Lee SC, Casadevall A. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun 1995; 63: 573–579
   PubMed Web of Science ®Google Scholar
• Mantovani B, Rabinovitch M, Nussenzweig V. Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med 1972; 135: 780–792
   PubMed Web of Science ®Google Scholar
• Dromer, F, Charreire, J, Contrepois, A, et al. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 1987; 55: 749–752
   PubMed Web of Science ®Google Scholar
• Blasi, E, Barluzzi, R, Mazzolla, R, et al. Biomolecular events involved in anticryptococcal resistance in the brain. Infect Immun 1995; 63: 1218–1222
   PubMed Web of Science ®Google Scholar
• Romani, L, Mencacci, A, Cenci, E, et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996; 183: 1345–1355
   PubMed Web of Science ®Google Scholar
• Mody, CH, Tyler, CL, Sitrin, RG, et al. Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol 1991; 5: 19–26
   PubMed Web of Science ®Google Scholar
• Griffin JA, Griffin FM. Augmentation of macrophage complement receptor function in vitro. I. Characterization of the cellular interactions required for the generation of a T lymphocyte product that enhances macrophage complement receptor function. J Exp Med 1979; 150: 653–675
   PubMed Web of Science ®Google Scholar
• Griffin FM, Griffin JA. Augmentation of macrophage complement receptor function in vitro. II. Characterization of the effects of a unique lymphokine upon the phagocytic capabilities of macrophages. J Immunol 1980; 125: 844–849
   PubMed Web of Science ®Google Scholar